{"id":49112,"date":"2026-05-05T11:35:15","date_gmt":"2026-05-05T11:35:15","guid":{"rendered":"https:\/\/quickassetsmarket.com\/index.php\/2026\/05\/05\/why-selling-these-3-dividend-stocks-could-be-a-mistake\/"},"modified":"2026-05-05T11:35:15","modified_gmt":"2026-05-05T11:35:15","slug":"why-selling-these-3-dividend-stocks-could-be-a-mistake","status":"publish","type":"post","link":"https:\/\/quickassetsmarket.com\/index.php\/2026\/05\/05\/why-selling-these-3-dividend-stocks-could-be-a-mistake\/","title":{"rendered":"Why selling these 3 dividend stocks could be a mistake"},"content":{"rendered":"<div><\/div>\n<p>Investors are uncomfortable seeing losses, especially in stocks they rely on for steady income.<\/p>\n<p>Enterprise Products Partners (NYSE: EPD), Pfizer (NYSE: PFE) and UPS (NYSE: UPS) all fit that uneasy profile as the share prices have been battered, and the yields are high enough to make some investors wonder whether the market is flashing a warning.<\/p>\n<p>But the deeper read is different as all three companies are still producing cash, all three are still paying their dividends, and in each case the payout remains tied to a business model that is more durable than the stock chart suggests.<\/p>\n<p>Current yields work out to about 5.7% for EPD, 6.5% for Pfizer and 6.8% for UPS at today\u2019s prices.<\/p>\n<h2 class=\"wp-block-heading\">EPD: Pipeline business built for ugly markets<\/h2>\n<p>Enterprise Products Partners is not an oil producer, so it does not live and die with commodity prices.<\/p>\n<p>It is a fee-based midstream operator that gets paid to transport, store and process hydrocarbons through a sprawling US network.<\/p>\n<p>That model matters because it turns EPD into something closer to a toll road than a bet on crude prices.<\/p>\n<p>The company says it has raised its distribution for 27 consecutive years, and its first-quarter 2026 results showed why income investors keep coming back.<\/p>\n<p>Enterprise generated $2.7 billion of distributable cash flow in the quarter and said that cash supported another 2.8% increase in the distribution.<\/p>\n<p>That is the key point for anyone tempted to sell after a slump. EPD\u2019s payout is not being funded by hope or leverage; it is being funded by recurring cash flow.<\/p>\n<p>The company retained $1.5 billion of DCF in the quarter after distributions, money it can use for growth projects, buybacks, or debt reduction.<\/p>\n<h2 class=\"wp-block-heading\">Pfizer: Market has already priced in a very grim future<\/h2>\n<p>Pfizer is the <a href=\"https:\/\/invezz.com\/news\/2026\/02\/03\/pfizer-maps-post-covid-reset-with-obesity-trials-and-deep-cost-cuts\/\">most bruised name in the group<\/a>. The stock is far below its pandemic-era peak, but the business is not standing still.<\/p>\n<p>Pfizer\u2019s 2025 annual review says revenue came in at $62.6 billion, and the company has continued to lean on cost cuts and its post-Seagen oncology portfolio as it tries to rebuild growth.<\/p>\n<p>It also just declared another $0.43 quarterly dividend, its 350th consecutive quarterly payout.<\/p>\n<p>The market\u2019s problem with Pfizer is not that the story is broken; it is that expectations are extremely low.<\/p>\n<p>The company reaffirmed its 2026 outlook for revenue of $59.5 billion to $62.5 billion and adjusted EPS of $2.80 to $3.00, while continuing to highlight cost savings and new-product momentum.<\/p>\n<p>That leaves room for a re-rating if execution stabilizes.<\/p>\n<p>In other words, investors selling now are not just taking a loss. They are also giving up a 6%-plus yield at a point when the stock is already priced for disappointment.<\/p>\n<h2 class=\"wp-block-heading\">UPS: Dividend is living through a restructuring<\/h2>\n<p>UPS is the hardest of the three to own because the business has been shrinking in places that used to matter a lot.<\/p>\n<p>But the company is clearly in a deliberate restructuring, not an uncontrolled decline.<\/p>\n<p>Its latest quarter showed $21.2 billion in revenue, with management reiterating a 2026 revenue target of about $89.7 billion and an adjusted operating margin goal of 9.6%.<\/p>\n<p>UPS has also said it is cutting Amazon volume sharply, while targeting about $3 billion in year-over-year cost savings in 2026 after roughly $600 million of savings in the first quarter alone.<\/p>\n<p>That matters because the dividend story rests on cash generation.<\/p>\n<p>UPS approved a quarterly dividend of $1.64 per share, and the company\u2019s annual report shows 2025 revenue of $88.7 billion.<\/p>\n<p>The yield is high because the share price is low, not because the payout has already cracked.<\/p>\n<p><em>This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own research or consult a qualified financial advisor before making any investment decisions.<\/p>\n<p><\/em><\/p>\n<p>The post <a href=\"https:\/\/invezz.com\/news\/2026\/05\/05\/why-selling-these-3-dividend-stocks-could-be-a-mistake\/\">Why selling these 3 dividend stocks could be a mistake<\/a> appeared first on <a href=\"https:\/\/invezz.com\">Invezz<\/a><\/p>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Investors are uncomfortable seeing losses, especially in stocks they rely on for steady income. Enterprise Products Partners (NYSE: EPD), Pfizer (NYSE: PFE) and UPS (NYSE: UPS) all fit that uneasy profile as the share prices have been battered, and the yields are high enough to make some investors wonder whether the market is flashing a <\/p>\n","protected":false},"author":1,"featured_media":49113,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":{"0":"post-49112","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investing"},"_links":{"self":[{"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/posts\/49112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/comments?post=49112"}],"version-history":[{"count":0,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/posts\/49112\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/media\/49113"}],"wp:attachment":[{"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/media?parent=49112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/categories?post=49112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/tags?post=49112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}